Reply to: Comments on “Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy”
Publication date: Available online 19 September 2020Source: European Journal of Surgical OncologyAuthor(s): W.J. Koemans, J.W. van Sandick, A.D.R. Huitema
Publication date: Available online 19 September 2020Source: European Journal of Surgical OncologyAuthor(s): Loek A.W. de Jong, Nielka P. van Erp, Philip R. de Reuver
CONCLUSION: The ad libitum lard-based LCHFD feeding of CP mice increases the peritoneal cytokine levels, which may reduce splenic anti-cancer lymphocytes and increase the number of Tregs in the peritoneal cavity and tumor. The detrimental effects of LCHFD are linked to dietary composition rather than overfeeding. This article is protected by copyright. All rights reserved. PMID: 32829500 [PubMed - as supplied by publisher]
Publication date: Available online 5 August 2020Source: European Journal of Surgical OncologyAuthor(s): W.J. Koemans, R.T. van der Kaaij, E. Wassenaar, C. Grootscholten, H. Boot, D. Boerma, M. Los, O. Imhof, J.H.M. Schellens, H. Rosing, A.D.R. Huitema, J.W. van Sandick
CONCLUSION: Our predictive model is based on the MELD score, polymorphonuclear cells, blood N, hepatocellular carcinoma, and renal dysfunction. This model may improve the early diagnosis of asymptomatic SBP. PMID: 32848336 [PubMed - in process]
Publication date: Available online 15 July 2020Source: International Journal of Surgery Case ReportsAuthor(s): Kazuhiko Hashimoto, Yujiro Fujie, Junya Fujita, Tadashi Ohnishi
ConclusionPTBD can be effectively and safely performed even in situations deemed to predispose patients to increased risk for adverse events. Thus, the mere presence of these conditions should not cause a denial of PTBD.
We present a patient with tuberculous peritonitis masquerading as carcinomatosis. High clinical suspicion, appropriate identification of bacterial isolates of theMycobacterium tuberculosis complex, and susceptibility testing are crucial to select target therapy. AbstractTuberculous peritonitis may debut with unspecific symptoms that can pose a diagnostic challenge for clinicians. We present a patient with tuberculous peritonitis masquerading as carcinomatosis. High clinical suspicion, appropriate identification of bacterial isolates of theMycobacterium tuberculosis complex, and susceptibility testing are crucial to select target therapy.
Abstract PURPOSE: We aimed to differentiate tuberculous peritonitis (TBP) from peritoneal carcinomatosis (PC) using a visual positron-emission tomography/computed tomography (PET/CT) scoring system based on mesenteric fluorodeoxyglucose (FDG) uptake. METHODS: PET/CT scans from 31 patients with TBP and 92 patients with PC were retrospectively reviewed. A visual PET/CT scoring system for mesenteric FDG uptake was used according to the following characteristics: FDG uptake intensity (low = 0, moderate = 1, high = 2), FDG uptake deposits (uniform = 0, irregular = 1, ascitic = 2), FDG uptake focality (diffuse = 0,...
We report the case of an 82-year-old male diagnosed with a metastatic castration resistant prostate carcinoma, under chemotherapy with disease progression in treatment with high doses of intravenous morphics. The patient reported abdominal distension with constipation and no vomiting in the emergency department and a distended and tympanic abdomen, without generalized peritonitis was identified during physical examination. A blood analysis showed lactate levels of 0.9 mmol/L and a PCR of 4.2 mg/L without leukocytosis. An extensive colonic pneumatosis with minimum pneumoperitoneum without free fluid was confirmed by a compu...
Chronic liver diseases (CLD) are a worldwide clinical problem, as they are related to high morbidity and mortality. The principal causes include viral, alcoholism, cholestatic, autoimmune and metabolic diseases such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). These CLD can evolve into cirrhosis and hepatocellular carcinoma (HCC) . Patients with CLD showed significant health problems like ascites, spontaneous bacterial peritonitis, hepatic encephalopathy and persistent variceal bleeding concomitant with a decrease in health-related quality of life [1-3].